VeriMomcocamidopropyl hydroxysultaine은 임신 중 안전한가요?
No harmonised reproductive classification or SCCS/CIR repro flag was identified. Repeated-dose/oral (OECD 422) studies reported a developmental/reproductive NOAEL around 300 mg/kg/day and agencies reviewing the data (registration dossiers / national assessments) concluded no developmental toxicity at doses ≤300 mg/kg/day, so there is no evidence of a reproductive hazard. For topical cosmetic use systemic absorption is expected to be low but measurable, so exposure is scored as low (e=1). Sources: ECHA registration dossier and national assessment. (ECHA OECD 422 dossier; Canada final assessment).
Pregnancy-safe products containing cocamidopropyl hydroxysultaine
Related ingredients
Frequently asked questions
- cocamidopropyl hydroxysultaine은 임신 중 안전한가요?
- No harmonised reproductive classification or SCCS/CIR repro flag was identified. Repeated-dose/oral (OECD 422) studies reported a developmental/reproductive NOAEL around 300 mg/kg/day and agencies reviewing the data (registration dossiers / national assessments) concluded no developmental toxicity at doses ≤300 mg/kg/day, so there is no evidence of a reproductive hazard. For topical cosmetic use systemic absorption is expected to be low but measurable, so exposure is scored as low (e=1). Sources: ECHA registration dossier and national assessment. (ECHA OECD 422 dossier; Canada final assessment).
- cocamidopropyl hydroxysultaine은 모유 수유 중 안전한가요?
- No data indicating transfer to breastmilk or breastfeeding-specific adverse effects were found in authoritative dossiers or the published toxicology records. Animal studies show no reproductive/developmental hazard at relevant NOAELs; therefore hazard and mechanism scores are 0. Topical use implies low but measurable maternal systemic exposure, so breastfeeding exposure scored as low (e=1).
- cocamidopropyl hydroxysultaine은 아기 피부에 안전한가요?
- No infant-specific reproductive/toxic mechanism or developmental evidence was found. Because the ingredient has measurable absorption in systemic toxicity studies (oral) and topical cosmetics can be absorbed to a low extent in adults, infant skin (0–3 yr) — which has an immature barrier and higher surface-area-to-weight ratio — receives one point higher exposure (adult e=1 → baby e=2). No infant-specific hazards were identified in the searched sources.
- VeriMom은 cocamidopropyl hydroxysultaine을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 cocamidopropyl hydroxysultaine을 93/100 (알려진 위험 없음)로 평가합니다.
- 임신 중 cocamidopropyl hydroxysultaine 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.